全文获取类型
收费全文 | 1284379篇 |
免费 | 80553篇 |
国内免费 | 1908篇 |
专业分类
耳鼻咽喉 | 17827篇 |
儿科学 | 40896篇 |
妇产科学 | 33789篇 |
基础医学 | 183086篇 |
口腔科学 | 36311篇 |
临床医学 | 108252篇 |
内科学 | 251096篇 |
皮肤病学 | 30893篇 |
神经病学 | 98509篇 |
特种医学 | 48104篇 |
外国民族医学 | 231篇 |
外科学 | 188425篇 |
综合类 | 22775篇 |
现状与发展 | 1篇 |
一般理论 | 301篇 |
预防医学 | 96926篇 |
眼科学 | 29573篇 |
药学 | 101467篇 |
7篇 | |
中国医学 | 3607篇 |
肿瘤学 | 74764篇 |
出版年
2021年 | 11698篇 |
2019年 | 11947篇 |
2018年 | 17356篇 |
2017年 | 12715篇 |
2016年 | 14021篇 |
2015年 | 15540篇 |
2014年 | 20714篇 |
2013年 | 30209篇 |
2012年 | 43232篇 |
2011年 | 45484篇 |
2010年 | 26002篇 |
2009年 | 23666篇 |
2008年 | 40933篇 |
2007年 | 43594篇 |
2006年 | 43860篇 |
2005年 | 41955篇 |
2004年 | 39731篇 |
2003年 | 37937篇 |
2002年 | 36502篇 |
2001年 | 66107篇 |
2000年 | 68078篇 |
1999年 | 56261篇 |
1998年 | 13823篇 |
1997年 | 11959篇 |
1996年 | 11909篇 |
1995年 | 11101篇 |
1994年 | 9984篇 |
1993年 | 9432篇 |
1992年 | 40562篇 |
1991年 | 38799篇 |
1990年 | 38169篇 |
1989年 | 36423篇 |
1988年 | 32864篇 |
1987年 | 31786篇 |
1986年 | 30042篇 |
1985年 | 28154篇 |
1984年 | 20426篇 |
1983年 | 17219篇 |
1982年 | 9480篇 |
1979年 | 18392篇 |
1978年 | 12317篇 |
1977年 | 11089篇 |
1976年 | 9621篇 |
1975年 | 11076篇 |
1974年 | 12891篇 |
1973年 | 12542篇 |
1972年 | 11957篇 |
1971年 | 11239篇 |
1970年 | 10349篇 |
1969年 | 10098篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
The absence of the temporary incisors could be to a genetic illness or to some multiple premature extractions. These extractions are the aftermaths of the carious lesions or some traumatisms underwent by the temporary incisors. Beyond measure the loss of the space, the premature loss some temporary incisors very often assign the relational development of the child and disturb its psychological development and the aesthetic function. Across some cases clinics, the authors show that the replacement of the temporary incisors is the therapeutic ideal solution. Indeed, the child prosthesis, replacing the temporary absent incisors, solves the psychological, aesthetic and relational problems of the child. 相似文献
73.
74.
O Schouten J H H van Laanen E Boersma R Vidakovic H H H Feringa M Dunkelgrün J J Bax J Koning H van Urk D Poldermans 《European journal of vascular and endovascular surgery》2006,32(1):21-26
OBJECTIVE: To evaluate the effect of statins on aneurysm growth in a group of consecutive patients under surveillance for infrarenal aortic aneurysms (AAA). MATERIALS AND METHODS: All patients (59 statin users, 91 non-users) under surveillance between January 2002 and August 2005 with a follow-up for aneurysm growth of at least 12 months and a minimum of three diameter evaluations were retrospectively included in the analysis. Multiple regression analysis, weighted with the number of observations, was performed to test the influence of statins on AAA growth rate. RESULTS: During a median period of 3.1 (1.1-13.1) years the overall mean aneurysm growth rate was 2.95+/-2.8 mm/year. Statin users had a 1.16 mm/year lower AAA growth rate compared to non-users (95% CI 0.33-1.99 mm/year). Increased age was associated with a slower growth (-0.09 mm/year per year, p = 0.003). Female gender (+1.82 mm/year, p = 0.008) and aneurysm diameter (+0.06 mm/year per mm, p = 0.049) were associated with increased AAA growth. The use of non-steroidal anti-inflammatory drugs, chronic lung disease, or other cardiovascular risk factors were not independently associated with AAA growth. CONCLUSIONS: Statins appear to be associated with attenuation of AAA growth, irrespective of other known factors influencing aneurysm growth. 相似文献
75.
Ohne Zusammenfassung 相似文献
76.
K P Sylvester S R Desai A U Wells D M Hansell M Awogbade S L Thein A Greenough 《The European respiratory journal》2006,28(4):832-838
The aim of this study was to determine whether patients with sickle cell disease (SCD) in steady state had pulmonary abnormalities seen on high-resolution computed tomography (HRCT) and whether any abnormalities correlated with contemporaneously diagnosed lung function abnormalities. A subsidiary question was whether the results of a noninvasive measure of haemolysis (end-tidal carbon monoxide (ETCO) levels) correlated with pulmonary function abnormalities. Thirty three patients with SCD, median (range) age 36 yrs (17-67 yrs) were examined. The degree of lobar volume loss and ground-glass opacification and prominence of central vessels on HRCT were quantitatively assessed. Pulmonary function was assessed by measurements of lung volumes, spirometry, gas transfer and oxygen saturation. ETCO levels were measured using an end-tidal CO monitor. Forced expiratory volume in one second (FEV1), forced vital capacity and total lung capacity significantly correlated with HRCT findings, particularly lobar volume loss. ETCO levels significantly negatively correlated with FEV1, vital capacity measured using a plethysmograph, specific airway conductance and arterial oxygen saturation measured by pulse oxymetry. In conclusion, the present results suggest that high-resolution computed tomography noninvasive assessment of haemolysis might be useful to identify sickle cell disease patients with respiratory function impairment. 相似文献
77.
J Müller-Quernheim K I Gaede E Fireman G Zissel 《The European respiratory journal》2006,27(6):1190-1195
An increase in chronic beryllium disease (CBD) has been suggested due to higher industrial use of beryllium alloys. Since occupational CBD is a perfect phenocopy of sarcoidosis, it might be misdiagnosed as sarcoidosis. In the current it was hypothesised that CBD exists in cohorts of sarcoidosis patients. In a prospective case study, sarcoidosis patients were evaluated for potential beryllium exposure. In those patients in whom beryllium exposure was confirmed and beryllium hypersensitivity demonstrated, the diagnosis of sarcoidosis was rejected and corrected to CBD. In 84 patients seen for re-evaluation or making a diagnosis of sarcoidosis, beryllium exposure was recognised and a diagnosis of CBD was made in 34 out of 84 patients. The time lag between clinical diagnosis of sarcoidosis and the final diagnosis of CBD ranged 0-18 yrs (median 3 yrs) and the mean (range) age at time of diagnosis of CBD was 43.9(25-80) yrs. Beryllium-contaminated workplaces causing disease encompassed a wide spectrum of industries and technical trades in which beryllium-exposure is generally not perceived as a health hazard. In conclusion, chronic beryllium disease still belongs to the spectrum of differential diagnoses of granulomatous disorders. 相似文献
78.
C. M. Crceles J. M. Serrano P. Marín E. Escudero E. Fernndez‐Varn 《Transboundary and Emerging Diseases》2006,53(6):300-304
The pharmacokinetics (PK) of moxifloxacin in healthy white New Zealand rabbits was studied following intravenous (IV) and subcutaneous (SC) administration routes as well as a SC long‐acting poloxamer 407 gel formulation (SC‐P407). Moxifloxacin concentrations were determined by high‐performance liquid chromatography assay with fluorescence detection. Mean half‐life for IV, SC and SC‐P407 routes was 2.15, 5.41 and 11.09 h. Clearance value after IV dosing was 0.78 l/kg/h. After SC administration, the mean absolute bioavailability was 117% and the Cmax was 1.61 ± 0.49 mg/l. After SC‐P407 administration, the bioavailability was 44% and the Cmax 1.83 was ±0.62 mg/l. No adverse effects were observed in any of the rabbits following IV, SC and SC‐P407 administration of moxifloxacin. Minimal inhibitory concentrations of moxifloxacin against different strains of Staphylococcus aureus from different european countries were used to compute the main pharmacodynamic (PD) surrogate markers of efficacy. The high tolerability of this SC‐P407 formulation and the favourable PK behaviour such as the long half‐life, acceptable bioavailability and excellent PK–PD ratios achieved indicate that it is likely to be effective in rabbits. 相似文献
79.
80.